SJIM
NVAX icon

St. Johns Investment Management’s Novavax NVAX Stock Holding History

St. Johns Investment Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-92
Closed -$10K – 178
2020
Q4 		$10K Hold
92
– – 0.01% 117
2020
Q3 		$10K Buy
+92
New +$11.2K 0.01% 114

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

St. Johns Investment Management's NVAX Position: Q1 2021 in Review

St. Johns Investment Management sold out of Novavax (NVAX) in Q1 2021, closing a stake of 92 shares — an estimated $10K sold.

St. Johns Investment Management first reported a position in NVAX in Q3 2020 and held it in 2 quarters. The position peaked at $10K in Q4 2020. 389 funds tracked by Wall St. Rank hold NVAX as of Q1 2021.

  • St. Johns Investment Management reported no remaining Novavax position as of Q1 2021 after selling out during the quarter.
  • St. Johns Investment Management sold 92 Novavax shares in Q1 2021, an estimated $10K.
  • St. Johns Investment Management first reported a position in Novavax in Q3 2020 and held it in 2 quarters.
  • St. Johns Investment Management's Novavax position peaked at $10K in Q4 2020.
  • 389 funds tracked by Wall St. Rank held Novavax as of Q1 2021.

Based on St. Johns Investment Management's 13F filing for Q1 2021, filed 30 Apr 2021.